Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
Ontology highlight
SUBMITTER: Leung NHL
PROVIDER: S-EPMC10528748 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA